Formycon mit Sitz in Martinsried bei München entwickelt biopharmazeutische Nachahmerprodukte für die Zulassung in Europa, USA und Japan. Biopharmazeutika (Antikörper) werden bei Krebs eingesetzt.
COMPANY
INVESTOR TERMSHEET
FYB
Formycon
#BGFL Mood:
-
·
#BGFL-Indicator:
-
·
Review date:
-
LEI:
39120005TZ76GQOY8Z19
SECTOR:
Gesundheit
SUB-SECTOR:
Biotechnologie
NAME
Formycon
WKN
A1EWVY
ISIN
DE000A1EWVY8
TICKER
FYB
INDEX
SDAX
EXCHANGE
Xetra
The basic chart view shows the price movement of Formycon. If you are interested in additional analysis switch to the advanced chart view.
Visualisation of financial information has been one of boersengefluester.de's (BGFL) favourite disciplines from the very beginning. For this reason, we also put a lot of effort into maintaining our own database and have developed numerous analysis tools and key figure tables on this basis.
Even hardened fundamentalists probably look at the chart of a share before they start analysing it in any other way. Accordingly, boersengefluester.de (BGFL) has also developed a wide range of apps relating to chart technology and sophisticated scorings with technical chart components.
Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
